Please login to the form below

Not currently logged in
Email:
Password:

dengue vaccine

This page shows the latest dengue vaccine news and features for those working in and with pharma, biotech and healthcare.

Sanofi sells European generics to Advent for $2.4bn

Sanofi sells European generics to Advent for $2.4bn

such as dengue fever vaccine Dengvaxia to deliver revenues as expected.

Latest news

  • Sanofi confirms suspected safety issue with dengue vaccine Sanofi confirms suspected safety issue with dengue vaccine

    Sanofi confirms suspected safety issue with dengue vaccine. As rival Takeda conduct phase II testing for its own dengue vaccine candidate. ... The setbacks for Dengvaxia provide an opportunity for rival Takeda to leapfrog Sanofi with its own dengue

  • Takeda dengue vaccine data looks good as it chases Sanofi Takeda dengue vaccine data looks good as it chases Sanofi

    Takeda dengue vaccine data looks good as it chases Sanofi. TAK-003 achieved a 71% reduction in developing the virus compared to placebo. ... Takeda’s chances of stealing a march on rival Sanofi in the dengue fever vaccine market look increasingly high

  • Takeda plans German plant to support dengue vaccine roll-out Takeda plans German plant to support dengue vaccine roll-out

    Takeda plans German plant to support dengue vaccine roll-out. Will invest more than 100m in the Singen manufacturing facility. ... Our colleagues in Singen have vast experience in lyophilisation technology, which is key for the manufacturing process of

  • Sanofi takeover bid rebuffed by Medivation Sanofi takeover bid rebuffed by Medivation

    However, it is going through a fertile stage at present, with recent approvals for cholesterol drug Praluent (alirocumab) and dengue fever vaccine Dengvaxia and new diabetes hope LixiLan (lixisenatide/insulin glargine)

  • Sanofi and Merck & Co dissolve longstanding vaccines alliance Sanofi and Merck & Co dissolve longstanding vaccines alliance

    The decision to part company comes at a time when both big pharma partners have promising vaccine candidates coming through their R&D pipelines. ... In Sanofi's case the company has just started rolling out the first-ever vaccine for dengue fever and has

More from news
Approximately 1 fully matching, plus 18 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Anthill is a specialist digital agency and a strategic partner for life science companies....

Latest intelligence

The Holy Grail of HCP Access
This is the data you need to gain access....
No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....

Infographics